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Abstract
Background: Schistosomiasis is a neglected tropical disease, endemic in 76 countries, that afflicts more than 240 million
people. The impact of schistosomiasis on infertility may be underestimated according to recent literature. Extracts of
Schistosoma haematobium include estrogen-like metabolites termed catechol-estrogens that down regulate estrogen
receptors alpha and beta in estrogen responsive cells. In addition, schistosome derived catechol-estrogens induce
genotoxicity that result in estrogen-DNA adducts. These catechol estrogens and the catechol-estrogen-DNA adducts can be
isolated from sera of people infected with S. haematobium. The aim of this study was to study infertility in females infected
with S. haematobium and its association with the presence of schistosome-derived catechol-estrogens.
Methodology/Principal Findings: A cross-sectional study was undertaken of female residents of a region in Bengo
province, Angola, endemic for schistosomiasis haematobia. Ninety-three women and girls, aged from two (parents
interviewed) to 94 years were interviewed on present and previous urinary, urogenital and gynecological symptoms and
complaints. Urine was collected from the participants for egg-based parasitological assessment of schistosome infection,
and for liquid chromatography diode array detection electron spray ionization mass spectrometry (LC/UV-DAD/ESI-MSn) to
investigate estrogen metabolites in the urine. Novel estrogen-like metabolites, potentially of schistosome origin, were
detected in the urine of participants who were positive for eggs of S. haematobium, but not detected in urines negative for
S. haematobium eggs. The catechol-estrogens/ DNA adducts were significantly associated with schistosomiasis (OR 3.35;
95% CI 2.32–4.84; P#0.001). In addition, presence of these metabolites was positively associated with infertility (OR 4.33;
95% CI 1.13–16.70; P#0.05).
Conclusions/Significance: Estrogen metabolites occur widely in diverse metabolic pathways. In view of the statistically
significant association between catechol-estrogens/ DNA adducts and self-reported infertility, we propose that an estrogen-
DNA adduct mediated pathway in S. haematobium-induced ovarian hormonal deregulation could be involved. In addition,
the catechol-estrogens/ DNA adducts described here represent potential biomarkers for schistosomiasis haematobia.
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Introduction
At least 243 million people are infected with schistosomes, and
more than half of these cases are caused by Schistosoma haematobium,
the causative agent of urogenital schistosomiasis [1,2,3]. Indeed
the number of cases of S. haematobium may be much greater than
previously believed - perhaps as many as triple that of earlier
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estimates of prevalence [4]. If confirmed, urogenital schistosomi-
asis may represent the most common neglected tropical disease in
sub-Saharan Africa [5]. The adult stages of the blood flukes are
long-lived within the venous plexi draining the pelvic organs
including the urinary bladder, uterus, vagina, seminal vesicles and
prostate [6]. The terminal spine eggs released continuously from
the female schistosomes migrate from the circulation by breaking
through the endothelial cells lining the venules. Thereafter, they
traverse the wall of the urinary bladder to the lumen from where
they exit to the exterior environment with the urine, to complete
the transmission of this neglected tropical disease pathogen.
Problematically, many schistosome eggs fail to exit the body,
and lodge with interstitial tissues of these organs. Entrapped eggs
of S. haematobium induce granulomata and may be identified as
various clinical presentations of ‘sandy patches’ and other signs
and symptoms [3]. Hematuria is caused by the inflammation
induced by entrapped eggs in the bladder and ureters. In addition,
organ damage can follow obstruction of the ureters, as can
secondary urinary tract and renal infections, hydronephrosis and
renal failure [3]. Moreover, eggs of S. haematobium are biological
carcinogens, grouped with a dozen or so other Group 1 microbes
by the World Health Organization’s (WHO) International Agency
for Research on Cancer [7]. Chronic exposure to the eggs of S.
haematobium frequently leads to squamous cell carcinoma of the
bladder (SCC), the incidence of which is highest in regions
endemic for S. haematobium [8,9]. Indeed, SCC is one of the most
serious complications of chronic schistosomiasis haematobia
[4,8,9,10,11]. In addition, the schistosomiasis haematobia likely
influences endocrine homeostasis based in part on its ability of the
blood flukes to synthesize and release estradiol [12,13].
We reported that extracts of S. haematobium worms include
estrogen-related metabolites that down-regulate estrogen receptors
(ER) alpha and beta in estrogen responsive cells in vitro [13].
Further, we identified estrogen metabolites in S. haematobium eggs
by mass spectrographic analysis and also detected these schisto-
some-derived estrogens in sera of S. haematobium-infected persons.
These estrogen-like metabolites belong to the catechol-estrogen
family of molecules [14]. Estrogens arise by aromatization of
androstenedione and testosterone, catalyzed by cytochrome P450
(CYP) 19, aromatase. They are metabolized by two major
pathways – (1) formation of catechol estrogens and (2) 16a-
hydroxylation [15] (Fig. 1). The natural estrogens, estrone (E1),
and estradiol (E2), are metabolized at the 2- or 4-position with the
formation of catechol estrogens that, in turn, are metabolically
oxidized into catechol estrogen quinones (CEQ). CEQ have been
implicated in the etiology of cancers [16]; the interaction of CEQ,
in particular CE-3,4-Q, with DNA produces depurinating
adducts, which may generate DNA apurinic sites that, in turn,
initiate mutations [17]. In the catechol pathway, the metabolism
involves further oxidation to semiquinones and quinones, includ-
ing formation of the catechol estrogen-3,4-quinone, the major
mutagenic derivative of estrogen [18]. Estrogen-derived metabo-
lites associated with carcinogenesis in diverse tissues including the
breast and thyroid [18,19,20] might impact target cells either as
hormones (hence affecting gene expression regulation) and/or as
carcinogens that are directly genotoxic leading to formation of
chromosomal DNA-adducts. Both mechanisms could be involved
in carcinogenesis [20].
Given that the eggs of S. haematobium secrete novel catechol-
estrogens, and that in other contexts, estrogens are metabolized to
active quinones that modify DNA [14], we now hypothesize that
infertility during infection with S. haematobium might be related to
the presence of parasite-derived catechol-estrogens. To begin to
address this issue, which may have substantial implications for
global health, here we undertook a cross-sectional study of
residents of rural Angola, a region endemic for schistosomiasis
haematobia [21]. A significant association between the presence of
catechol-estrogens/ DNA adducts in the urine of females who
were urine egg-positive for S. haematobium infection and self-
reported infertility was detected.
Methods
Study area
Bengo province is a rural region, close to Luanda, the capital
city of Angola. The study was performed in 2011 and 2012 at the
Clı´nica da Sagrada Esperanc¸a, Luanda, Angola. This clinic serves
the residents of Bengo. S. haematobium is endemic in this province;
transmission occurs proximal to the Muxima River (Fig. 2). Bengo
has a population of 500,000 inhabitants most of whom are
involved with rural activities.
Study population and design
Irrespective of symptoms, 93 females willing to provide a urine
sample were enrolled in the study. The ages of these participants
ranged from 2 to 93 years. All participants provided oral informed
consent. They all were advised that were free to withdraw from the
study at any time, without the need for an explanation. Oral
informed consent was documented by the physician performing
the interviews. Written informed consent could not be obtained
because participants were illiterate. Parents provided informed
consent on behalf of participating children. Ethical approval for
the study protocol, including the use of oral consent, was obtained
from the review board (the local ethics committee) of Clinica da
Sagrada Esperanc¸a, Luanda, Angola. The 93 volunteers were
arbitrarily assigned to three age categories: 2–11 years (children),
37 participants; 12–19 years (adolescents), 17 participants; and 20–
94 years (women), 39 participants.
Urine examination
Patients provided one sample of urine of ,50 ml volume,
collected at the time of the interview. The entire micturition
volume was filtered through a polycarbonate membrane of 14 mm
mesh size and 25 mm diameter (Whatman plc, Springfield Mill,
UK). Thereafter the membrane was stained with Trypan blue
(Sigma-Aldrich Corp, St. Louis, MO). Schistosome ova retained
on the membrane were identified with the aid of a light
microscope, as described [22].
Medical history and clinical examination
Interviews were undertaken in a relaxed atmosphere. It was
emphasized to the participants by the project leaders that the
consultation was confidential and voluntary. Personal data were
obtained in order to facilitate (subsequent) follow-up in the advent
of subsequent appearance of cancer or other illnesses. Each
participant was asked questions related to previous and present
urinary system symptoms, gynecological complaints and general
medical history and treatments. Regarding the fertility status,
participants were assigned to one of three groups conforming to
the WHO’s definition of infertility: ‘‘Infertility is the inability of a
woman to become pregnant after one year of sexual intercourse
without using contraception, with primary infertility considered
when the woman never conceived, and secondary infertility when
she had had a previous labour’’ [23]. Thus, in accordance, groups
were defined as those who reported absence of difficulties in
becoming pregnant (Group 1); those who were unable to become
pregnant after one year of trial (self-reported primary infertility -
Group 2); and those who had previously borne one child but could
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Figure 1. Major metabolic pathways in cancer initiation by estrogens. Adapted from [21,22].
doi:10.1371/journal.pone.0096774.g001
Figure 2. Map of Angolan study area. Adapted from [42].
doi:10.1371/journal.pone.0096774.g002
Urogenital Schistosomiasis - Self-Reported Infertility
PLOS ONE | www.plosone.org 3 May 2014 | Volume 9 | Issue 5 | e96774
not achieve a second child (self-reported secondary infertility -
Group 3). An urologist (JS) performed the interviews.
Liquid Chromatography Diode Array Detection Electron
Spray Ionization Mass Spectrometry (LC/UV-DAD/ESI-
MSn)
Analysis using LC/UV-DAD/ESI-MSn was performed on a
Finnigan Surveyor Plus High-Performance Liquid Chromatogra-
phy (HPLC) instrument (ThermoFinnigan, San Jose, CA)
equipped with a diode-array detector and a mass detector. The
HPLC system included a quaternary pump, autosampler,
degasser, photodiode-array detector and automatic thermostatic
column compartment, and was controlled by the Xcalibur
software package (ThermoFinnigan). The mass detector was a
Finnigan Surveyor LCQ XP MAX quadrupole ion trap mass
spectrometer (ThermoFinnigan) equipped with an electron spray
ionization (ESI) interface. Control and data acquisition were
carried out with Xcalibur. Nitrogen gas of .99% purity was
employed with a pressure of 520 kPa (75 psi). The instrument was
operated in a negative-ion mode with an ESI needle voltage of
5.00 kV and capillary temperature of 325 uC. The full scan
covered the mass range from 50–2,000 m/z (mass/charge number
of ions). Mass spectrometry (MSn) data were simultaneously
acquired for the selected precursor ion. Collision Induced
Dissociation-Tandem Mass Spectrometry (CID-MS/MS) and
MSn analyses were performed using helium with collision energy
of 25–35 eV. The HPLC used a LiChroCART C18 column
(125 mm64 mm; 5 mm particle diameter, end-capped) with the
temperature maintained at 25 uC; the mobile phase was composed
of 1% (v/v) acetic acid in water (A) and acetonitrile, which had
been degassed and filtered (B). The gradient used was 0–5 min
with 100% A; 5–10 min, linear gradient from 100% to 80% A;
10–15 min, 80% A; 15–50 min, linear gradient from 80% to 40%
A; 50–65 min, 40% A; 65–75 min, linear gradient from A to
100% B. The flow rate was 0.3 ml min21 followed to split out in
200 ml min21 to MS. Spectral data for all peaks were accumulated
in the range of 200–600 nm. The instrument was calibrated with
caffeine (Sigma-Aldrich), Met-Arg-Phe-Ala (MRFA) (tetrapeptide,
Thermo Finnigan), and Ultramark 1621 (Lancaster Synthesis,
Ward Hill, MA) in the mass range of 195–1,821 m/z. An
advantage of inclusion of a MS detector over conventional HPLC
analysis is that the number of channels in the detector can be set to
specifically and separately identify all estrogen related compounds
in a single injection of the urine sample.
Statistical analysis
Groups -- schistosomiasis positive and negative, presence or
absence of metabolites -- were compared using the chi-square test
with Yate’s correction or with Fisher’s exact, two-sided test when
expected values were below 5. The chi-square test was used
because it compares categorical variables. The data were normally
distributed. Differences were considered statistically significant
where P#0.05 (VassarStats, Poughkeepsie, NY).
Results
Association between self-reported infertility and the
presence of Schistosoma haematobium eggs in the urine
All 93 participants had lived in the area for at least two years.
Urinary S. haematobium infection was diagnosed when schistosome
ova were identified in the urine. The participants were assigned to
one of two groups: positive and negative for S. haematobium
infection. The median age was 22.9 (range 6 to 94) years for S.
haematobium-positive and 27.3 (2 to 88) years for S. haematobium-
negative females (Table 1). The fertility status of the women,
excluding the prepubescent population (2–12 years old), and the
presence of S. haematobium eggs in urine revealed 24 fertile and 29
women with a history of self-reported infertility --14 in Group 2,
i.e. unable to become pregnant after one year trial, and 15 in
Group 3, i.e. had borne fewer children than desired (Table 2). In
general, signs and symptoms reported by the participants were
distributed similarly between the groups, S. haematobium +ve and S.
haematobium –ve, including dysuria, lower abdominal pain, history
of water contact, etc. (Table 3).
Novel estrogen-like metabolites detected in urine of
females positive for eggs of S. haematobium
Analysis of urine was undertaken using by LC/DAD/ESI-MSn.
Inspection of the chromatography revealed several intense peaks,
and four of these peaks corresponded to novel metabolites with
catechol-estrogen-quinone radicals that, to our knowledge, have
not been described previously. We analyzed the estrogen-related
compounds using LC/DAD/ESI-MSn to yield the typical
intensity spectra of the representative estrogen derivatives obtained
by LC (Fig. 3). Each metabolite was detected and identified based
on the parameters that were ostensibly unique to it, including the
m/z value (m: atomic mass; z: atomic charge) and the retention
time (RT). This produced the ‘parent’ mass spectrum by MS
(parent m/z). Four new molecules were identified in S.
haematobium-positive participants, at 28.35, 32.96, 43.47 and
44.22 RT (time at which a peak appeared). The corresponding
RT of each peak was submitted to LC/DAD-ESI/MS and
revealed a unique high peak in each -- 305.33, 269.33, 481.33 and
495.33 mz, respectively. These spectra were not observed in urine
of non-schistosome infected participants (OR 3.35; 95% CI 2.32–
4.84; P#0.01). Thereafter, each of these peaks was submitted to
ICD/MS/MS, which produced the mass spectra for the ‘daugh-
ter’ ions (daughters m/z) (Fig. S1). The collision at high pressure
fragments the molecule at its most fragile sites, releasing several
smaller molecules. Values of the RT, parent m/z, daughter m/z
and the molecular mass of the four new catechols are provided in
the Table S1. The chemical structure of each metabolite was
reconstructed by overlaying the structures of the m/z’s of daughter
ions to ascertain whether they corresponded to the structure of
each parent m/z (Fig. 4). In each case, full confirmation of the
structural assignment for the four novel estrogen-like metabolites
was established.
Estrogen metabolites of schistosomes in urine: an
association with self-reported infertility
Comparisons between S. haematobium +ve and S. haematobium –ve
participants revealed a significant association between presence of
S. haematobium eggs in the urine and hematuria and presence of
estrogen metabolites in urine and Group 2 (self-reported primary
infertility) (Table 3). A significant association between self-reported
infertility (Group 2+3) and S. haematobium estrogen metabolites in
urine also was observed (Table 4).
Discussion
Female genital schistosomiasis (FGS) is common in rural regions
of sub-Saharan Africa; of the estimated 70 million children
currently infected with S. haematobium, approximately 19 million
girls and women will develop FGS in the coming decade [24]. Up
to 75% of girls and women with chronic S. haematobium infection
may be affected by deposition of eggs with granulomas and sandy
patches on the cervix and, moreover, histopathological interpre-
Urogenital Schistosomiasis - Self-Reported Infertility
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tation of biopsy specimens indicates that this increases the vascular
density of the genital mucosa. [25]. The resulting FGS has been
associated with contact bleeding, discharge, pain on intercourse, as
well as diminished fertility [26,27,28]. FGS can also be a source of
shame and stigma [26,29].
In this cross-sectional study of 93 girls and women, schistoso-
miasis haematobia was statistically associated with self-reported
primary infertility in these participants residing at a rural site,
Bengo province, Angola. The outcome corroborated findings from
case reports of decreased fertility in women with schistosomiasis
[26,27,28,29,30,31,32]. These reports had indicated the need for
further investigation given they dealt with only two community-
based studies [33,34]. Travelers who contract schistosomiasis
haematobia in endemic regions may be also at risk of infertility
[35,36]. FGS may induce pregnancy-related disorders, but the
data available so far are insufficient from which to draw firm
conclusions. Functional and anatomical disorders due to schisto-
some egg granuloma, including fibrosis of the ovaries and tubal
obstruction, are established causes of infertility [37]. Hormonal
disturbances during FGS may contribute to infertility and sub-
optimal fecundity [38]. In this regard, it is relevant to note that S.
haematobium expresses estrogenic molecules that down regulate the
expression of estrogen receptors in vitro [11,13]
Manifestations of FGS in the young are difficult to evaluate
because intra-vaginal inspection is only infrequently performed
before the onset of puberty and/or sexual activity. Moreover,
gynecological examination of people who have lived with these
conditions for long periods requires appropriate cultural insight
and skill in communication on the part of the investigators [26].
Accordingly, research in rural sites – including this present report
-- is challenging, and requires the establishment of a differential
diagnosis using non-invasive approaches [26]. Accordingly,
development of non-invasive tests for FGS, especially given the
potential for FGS- associated infertility, is a worthwhile goal that,
if accomplished, can be expected to improve the public health in
under-resourced and under-served populations. Based on the
present findings, we predict that a diagnostic method based on
mass spectrometric analysis of schistosome catechol estrogens in
urine of S. haematobium infected persons could provide a novel, less
invasive tool to complement current approaches.
Here, estrogen-like metabolites similar to those identified
previously in adult worm and eggs stages of S. haematobium
Table 1. Numbers of positive (S. haematobium +ve) and negative (S. haematobium -ve) urine samples for eggs of Schistosoma
haematobium according to the age of the participants.
Age groups (years) S. haematobium +ve S. haematobium -ve Total
median age (range) 22.9 (6–94) 27.3 (2–88) 25.1 (2–94)
2–11, i.e. children 18 19 37
12–19, i.e. adolescents 12 5 17
20–94 16 23 39
Total 46 47 93
doi:10.1371/journal.pone.0096774.t001
Table 2. Status of fertility among Angolan women who provides urine samples positive (S. haematobium +ve) and negative (S.
haematobium -ve) for eggs of Schistosoma haematobium, according to the age of the participants.
N (%) median age (years)
Age range
(years)
Non-reproductive females 40 (100%) 8.25 2–12
S. haematobium +ve 21 (52.5%) 9.3 6–12
S. haematobium –ve 19 (47.5%) 7.1 2–11
Fertile women (Group1) 24 (100%) 51 18–94
S. haematobium +ve 8 (33.3%) 52.5 18–94
S. haematobium –ve 16 (66.7%) 50.25 19–88
Self-reported infertility (Group 2+3)a 29 (100%) 26.9 17–41
S. haematobium +ve 17 (58.6%) 25.6 18–41
S. haematobium –ve 12 (41.4%) 28.8 17–40
Self-reported primary infertility (Group 2) 14 (100%) 18.8 17–21
S. haematobium +ve 10 (71.4%) 19 18–21
S. haematobium -ve 4 (28.6%) 18.3 17–19
Self-reported secondary infertility (Group 3) 15 (100%) 34.5 24–41
S. haematobium +ve 7 (46.7%) 35.1 27–41
S. haematobium -ve 8 (53.3%) 34 24–40
aWomen had been unable to become pregnant after one year of trial (self-reported primary infertility, Group 2) and those who had borne fewer children than they
desired (self-reported secondary infertility, Group 3).
doi:10.1371/journal.pone.0096774.t002
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[13,14] were detected by LC–MS in urine of study participants
with FGS, and were statistically associated with self-reported
infertility in the study volunteers. These electrophilic compounds
can react with DNA to form the depurinating adducts. It is not
inconceivable that apurinic sites in chromosomal DNA that result
from this type of reaction generate mutations that might underlie
infertility. Mutations in genes of the steroid enzyme pathway genes
can lead to autosomal recessive infertility [39]. The aromatase
enzyme, encoded by the CYP19 gene, converts the androgens
testosterone and androstenedione to estradiol and oestrone,
respectively. Therefore mutation in CYP19 gene results in
estrogen deficiency in both females and males [39]. To date, we
have not addressed male infertility caused by S. haematobium
infection, but we aim to address this aspect in future studies in
Bengo [6,40,41].
Even though our present report presents a statistical association
between the presence of estrogen metabolites in the urine of S.
haematobium-infected females and sub-fertility, several confounding
variables may weaken our hypothesis. First, questions about
gynecological complaints and sexual activities in adolescents were
asked in the presence of parents; this may have led to a systemic
underreporting of complaints and/or sexual activity in some of the
participants. Second, primary and secondary infertility due to
male-associated factors have not been analysed. Third, we did not
have access to information about number of abortions and/or
other associated gynecological diseases, or information concerning
treatment for schistosomiasis received by the study participants.
Given the context of the association between FGS and difficulty in
becoming pregnant, the presence of putative mutagenic catechol-
estrogens in S. haematobium infected persons may have practical
implications for development of new approaches to control FGS
and its sequelae. We have previously reported novel estrogenic
molecules in S. haematobium and sera from cases of schistosomiasis
haematobia [13,14]. We now present evidence, also by mass
Table 3. Symptoms and fertility state of 93 female residents of the Bengo region of Angola, an area endemic for schistosomiasis
haematobia.
Symptom Sh egg +ve; n =46 Sh egg –ve; n =47 OR 95% CI P-value
Hematuria 35 22 3.9 1.6–9.8 #0.01
Dysuria 26 23 1.43 0.63–3.25 0.27
Lower abdominal pain 24 22 1.3 0.57–2.95 0.34
History of water contact 37 39 1.1 0.38–3.14 0.54
Previous treatment with praziquantel 16 10 0.44 0.17–1.13 0.07
Estrogen metabolites 25 0 3.35 2.32–4.84 #0.01
Fertility status
Fertile 8/24 16/24 0.98 0.33–2.97 0.61
Group 2+3 17/29 12/29 1.02 0.34–3.07 0.60
Group 2 10/29 4/29 4.06 0.94–17.4 #0.03
Group 3 7/29 8/29 0.4 0.10–1.40 0.12
Women unable to become pregnant after one year of trial (self-reported primary infertility - Group 2) and those who had borne fewer children than desired (self-
reported secondary infertility - Group 3).
Sh egg +ve, positive for eggs of S. haematobium in urine; Sh egg –ve, negative for eggs of S. haematobium in urine.
OR, odds ratio; CI, confidence interval.
doi:10.1371/journal.pone.0096774.t003
Figure 3. Typical spectra of representative estrogen metabolites, which were obtained in a single injection. The m/z of the molecules
and the respective retention time at which they appear are highlighted.
doi:10.1371/journal.pone.0096774.g003
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Figure 4. Chemical structures, retention times (RT) and m/z values for the four main components identified by LC–MS analysis of
urine of Schistosoma haematobium-infected females. Atomic mass (m); atomic charge (z).
doi:10.1371/journal.pone.0096774.g004
Table 4. Numbers of positive (E+) and negative (E-) estrogen metabolites in urine samples according to the fertility status of the
study participants.
E + (n =25) E - (n =21) OR 95% CI P-value
Fertile women (ages) 2 (29, 63) 6 (28–94)
Group 2+3 (ages) 15 (19–41) 2 (21–34) 4.33 1.13–16.70 0.03
Group 2 (ages) 9 (18–20) 1 (21) 2.67 0.60–11.80 n.a.
Group 3 (ages) 6 (27–41) 1 (34) 4.75 0.51–44.50 n.a.
Total 17 8
#12 years 8 13
Total 25 21
Women unable to become pregnant after one year of trial (Self-reported primary infertility - Group 2) and those who had borne fewer children than desired (Self-
reported secondary infertility - Group 3).
OR, odds ratio; CI, confidence interval.
doi:10.1371/journal.pone.0096774.t004
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spectrometry, of the detection and characterization of similar
molecules in the urine of S. haematobium infected people, of which
the majority are catechol estrogen quinones.
The genotoxicity of estrogen metabolites might be attributed to
oxidation of catechol-estrogens to quinones followed by redox
cycling and formation of reactive oxygen species (ROS) that in
turn react with DNA [42,43]. The metabolism of estrogens and
the production of depurinating estrogen-DNA adducts as well as
the generation of ROS can be implicated in a pathway underlying
S. haematobium-promoted host cell DNA damage. The mutagenic
effect of this estrogen-DNA adduct mediated pathway could
explain the statistical association between S. haematobium infection
and reduced fertility. Given that the genome and transcriptomes of
eggs, female and male adult worms of S. haematobium is available
[44], studies utilizing RNA interference and/or other functional
genomic tools to silence components of estrogen catabolism
pathways e.g. schistosome estradiol 17beta-dehydrogenase should
be informative [45]. To conclude, given that the four novel
estrogen-like metabolites identified here in urine were associated
with both FGS and with difficulty in becoming pregnant, deeper
investigation in larger numbers of infected people and in other
geographical regions endemic for S. haematobium infection is clearly
worthwhile.
Supporting Information
Figure S1 Mass spectra of catechol estrogen quinones
from Schistosoma haematobium infected individuals by
MS (parent m/z) and MS/MS (daughters m/z). (A) m/z
305.33; (B) m/z 269.33; (C) m/z 481.33 and (D) m/z 495.53. The
top image corresponds to the m/z of the four estrogen metabolites
with catechol-quinone radicals (A–D) found at the retention times
(RT) illustrated in Fig. 3 and obtained by LC/DAD-ESI/MS. The
maximum peak of each (arrows) was submitted to CID/MS/MS,
where the collisions released the mass spectra of the ‘‘daughters’’
(bottom image: encircled). Atomic mass (m); atomic charge (z).
(PDF)
Table S1 Estrogen metabolites with spectrometric
masses of parent and daughter ions and retention times.
(DOCX)
Acknowledgments
We would like to show our deepest appreciation to the volunteers who
participated in the study, Afonso Domingues (from Faculty of Engineer,
University of Porto, Portugal) for figure revision and Manuela Vilac¸a and
Orquı´dea Conceic¸a˜o (from National Institute of Health, Porto, Portugal)
for sample handling and storage.
Author Contributions
Conceived and designed the experiments: MCB. Performed the experi-
ments: MJG NV MdLD. Analyzed the data: MCB MS GR PJB.
Contributed reagents/materials/analysis tools: JS LLS CL AG JMTdS
CO PX AB JMCdC PG. Wrote the paper: MCB MS GR PJB. Performed
the interviews: JS LLS CL.
References
1. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J (2006) Schistosomiasis and
water resources development: systematic review, meta-analysis, and estimates of
people at risk. Lancet Infect Dis 6: 411–425.
2. Hotez PJ, Kamath A (2009) Neglected tropical diseases in sub-Saharan Africa:
review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis
3: e412.
3. van der Werf MJ, de Vlas SJ, Brooker S, Looman CW, Nagelkerke NJ, et al.
(2003) Quantification of clinical morbidity associated with schistosome infection
in sub-Saharan Africa. Acta Trop 86: 125–139.
4. King CH (2010) Parasites and poverty: the case of schistosomiasis. Acta Trop
113: 95–104.
5. Brindley PJ, Hotez PJ (2013) Break Out: Urogenital schistosomiasis and
Schistosoma haematobium infection in the post-genomic era. PLoS Negl Trop
Dis 7(3): e1961.
6. Ramarakoto CE1, Leutscher PD, van Dam G, Christensen NO (2008)
Ultrasonographical findings in the urogenital organs in women and men
infected with Schistosoma haematobium in northern Madagascar. Trans R Soc
Trop Med Hyg 102:767–73.
7. Biological agents: a review of human carcinogens (2012) IARC Monogr. Eval.
Carcinog. Risks Hum. 100: 1–441. Available: http://monographs.iarc.fr/ENG/
Monographs/vol100B/.
8. Parkin DM (2006) The global health burden of infection-associated cancers in
the year 2002. Int J Cancer 118: 3030–3044.
9. Shiff C, Veltri R, Naples J, Quartey J, Otchere J, et al. (2006) Ultrasound
verification of bladder damage is associated with known biomarkers of bladder
cancer in adults chronically infected with Schistosoma haematobium in Ghana.
Trans R Soc Trop Med Hyg 100: 847–854.
10. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, et al. (2009) WHO
International Agency for Research on Cancer Monograph Working Group. A
review of human carcinogens—Part B: biological agents. Lancet Oncol 10: 321–
322.
11. Botelho MC, Machado JC, Brindley PJ, Correia da Costa JM (2011) Targeting
molecular signaling pathways of Schistosoma haemotobium infection in bladder
cancer. Virulence 2: 267–279.
12. Botelho MC, Crespo M, Almeida A, Vieira P, Delgado ML, et al. (2009)
Schistosoma haematobium and Schistosomiasis mansoni: production of an
estradiol-related compound detected by ELISA. Exp Parasitol 122: 250–253.
13. Botelho MC, Soares R, Vale N, Ribeiro R, Camilo V, et al. (2010) Schistosoma
haematobium: identification of new estrogenic molecules with estradiol
antagonistic activity and ability to inactivate estrogen receptor in mammalian
cells. Exp Parasitol 126: 526–535.
14. Botelho MC, Vale N, Gouveia MJ, Rinaldi G, Santos J, et al. (2013) Tumour-
like phenotypes in urothelial cells after exposure to antigens from eggs of
Schistosoma haematobium: an oestrogen-DNA adducts mediated pathway?
Int J Parasitol 43: 17–26.
15. Cavalieri E, Rogan E (2006) Catechol quinones of estrogens in the initiation of
breast, prostate, and other human cancers: keynote lecture. Ann N Y Acad Sci
1089: 286–301.
16. Cavalieri E, Chakravarti D, Guttenplan J, Hart E, Ingle J, et al. (2006) Catechol
estrogen quinones as initiators of breast and other human cancers: implications
for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta
1766: 63–78.
17. Markushin Y, Gaikwad N, Zhang H, Kapke P, Rogan EG, et al. (2006) Potential
biomarker for early risk assessment of prostate cancer. Prostate 66: 1565–1571.
18. Zahid M, Goldner W, Beseler CL, Rogan EG, Cavalieri EL (2013) Unbalanced
estrogen metabolism in thyroid cancer. Int J Cancer 133: 2642–2629.
19. Yager JD, Davidson NE (2006) Estrogen carcinogenesis in breast cancer. N.
Eng. J. Med 354: 270–282.
20. Cavalieri EL, Rogan EG (2011) Unbalanced metabolism of endogenous
estrogens in the etiology and prevention of human cancer. J Steroid Biochem
Mol Biol 125: 169–180.
21. Lopes LV, Conceic¸a˜o AV, Oliveira JB, Tavares A, Domingos C, et al. (2012)
Cancer in Angola, resources and strategy for its control. The Pan African
Medical Journal 12: 13
22. Feldmeier H, Bienzle U, Dietrich M, Sievertsen HJ (1979) Combination of a
viability test and a quantification method for Schistosoma haematobium eggs
(filtration—trypan blue-staining-technique). Tropenmed Parasitol 30: 417–422.
23. The International Committee for Monitoring Assisted Reproductive Technology
(ICMART) and the World Health Organization (WHO) Revised Glossary on
ART Terminology (2009). Available: http://www.who.int/reproductivehealth/
publications/infertility/art_terminology2/en/
24. Hotez PJ (2009) Empowering women and improving female reproductive health
through control of neglected tropical diseases. PLoS Negl Trop Dis 3: e559.
25. Jourdan PMB, Roald B, Poggensee G, Gundersen SG, Kjetland EF (2011)
Increased vascularity in cervicovaginal mucosa with Schistosoma haematobium
infection. PLoS Negl Trop Dis 5: e1170.
26. Kjetland EF, Leutscher PD, Ndhlovu PD (2012) A review of female genital
schistosomiasis. Trends Parasitol 28: 58–65.
27. Bullough CH (1976) Infertility and bilharziasis of the female genital tract.
Br J Obstet Gynaecol 83:819–22.
28. El-Mahgoub S (1982) Pelvic schistosomiasis and infertility. Int J Gynaecol Obstet
20(3): 201–206.
29. Takougang I, Meli J, Fotso S, Angwafo F 3rd, Kamajeu R, et al. (2004) Some
social determinants of urinary schistosomiasis in Northern Cameroon:
implications for schistosomiasis control. Afr J Health Sci 11: 111–120.
Urogenital Schistosomiasis - Self-Reported Infertility
PLOS ONE | www.plosone.org 8 May 2014 | Volume 9 | Issue 5 | e96774
30. Balasch J, Martı´nez-Roma´n S, Creus M, Campo E, Fortuny A, et al. (1995)
Schistosomiasis: an unusual cause of tubal infertility. Hum Reprod 10: 1725–
1727.
31. Goverde AJ, Schats R, van Berlo PJ, Claessen FA (1996) An unexpected guest in
follicular fluid. Hum Reprod 11: 531–532.
32. Schanz A, Richter J, Beyer I, Baldus SE, Hess AP, et al. (2010) Genital
schistosomiasis as a cause of female sterility and acute abdomen. Fertil Steril 93:
2075.e7–9.
33. Leutscher P, Ravaoalimalala VE, Raharisolo C, Ramarokoto CE, Rasendra-
mino M, et al. (1998) Clinical findings in female genital schistosomiasis in
Madagascar. Trop Med Int Health 3: 327–332.
34. Kjetland EF, Kurewa EN, Mduluza T, Midzi N, Gomo E, et al. (2010) The first
community-based report on the effect of genital Schistosoma haematobium infection
on female fertility. Fertil Steril 94: 1551–1553.
35. Dzeing-Ella A, Mechaı¨ F, Consigny PH, Zerat L, Viard JP, et al. (2009) Cervical
schistosomiasis as a risk factor of cervical uterine dysplasia in a traveler.
Am J Trop Med Hyg 81: 549–550.
36. Bailey SL, Price J, Llewelyn M (2011) Fluke infertility: the late cost of a quick
swim. J Travel Med 18: 61–62.
37. Poggensee G, Feldmeier H, Krantz I (1999) Schistosomiasis of the female genital
tract: public health aspects. Parasitol Today 15: 378–381.
38. Bindseil E, Andersen LL, Krog NL, Hau J (1991) Effect of extra-genital
Schistosoma mansoni and Echinostoma caproni infections on serum levels of
pregnancy-associated murine protein-1 during murine pregnancy. In Vivo 5:
175–177.
39. Layman LC (2002) Human gene mutations causing infertility. J Med Genet 39:
153–161.
40. Kini S, Dayoub N, Raja A, Pickering S, Thong J (2009) Schistosomiasis-induced
male infertility. BMJ Case Reports, doi:10.1136/bcr.01.2009.1481
41. Adisa J, Egbujo EM, Yahaya BA (2012) Primary infertility associated with
Schistosoma mansoni: a case report from the Jos plateau, north central Nigeria.
African Health Sciences 12: 563–5.
42. Cavalieri EL, Stack DE, Devanesan PD, Todorovic R, Dwivedy I, et al. (1997)
Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous
tumor initiators. Proc Natl Acad Sci U S A 94: 10937–10942.
43. Lu W, Ogasawara MA, Huang P (2007) Models of reactive oxygen species in
cancer. Drug Discov Today Dis Models 4: 67–73.
44. Young ND, Jex AR, Li B, Liu S, Yang L, et al. (2012) Whole-genome sequence
of Schistosoma haematobium. Nat Gen 44: 221–225.
45. Rinaldi G, Okatcha TI, Popratiloff A, Ayuk MA, Suttiprapa S, et al. (2011)
Genetic manipulation of Schistosoma haematobium, the neglected schistosome.
PLoS Negl Trop Dis 5: e1348.
Urogenital Schistosomiasis - Self-Reported Infertility
PLOS ONE | www.plosone.org 9 May 2014 | Volume 9 | Issue 5 | e96774
